| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.089 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.085 | 0.08 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.078 | 0.08 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |